Literature DB >> 25160548

Horner syndrome after tonsillectomy: an anatomic perspective.

Christina Giannikas1, Howard D Pomeranz2, Lee P Smith3, Zipora Fefer4.   

Abstract

BACKGROUND: Horner syndrome after tonsillectomy has been reported rarely in the literature. Furthermore, postoperative Horner syndrome lasting more than a 1 month is an even more rare occurrence. PATIENT: We present a persistent postoperative Horner syndrome in a 5-year-old child following tonsillectomy.
RESULTS: Clinical diagnosis of Horner syndrome is confirmed pharmacologically, and damage to the oculosympathetic pathway at the level of the superior cervical ganglion is radiographically demonstrated.
CONCLUSION: Conventional monopolar electrosurgical dissection led to irreversible damage of ganglionic neural tissue at the level of the palatine tonsilar fossa and permanent Horner syndrome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Horner syndrome; anhidrosis; anisocoria; meiosis; oculosympathetic paresis; ptosis; tonsillectomy

Mesh:

Year:  2014        PMID: 25160548     DOI: 10.1016/j.pediatrneurol.2014.05.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

Review 1.  Imaging of Horner syndrome in pediatrics: association with neuroblastoma.

Authors:  Hedieh Khalatbari; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2020-10-06

2.  Anatomic study of the musculus longus capitis flap.

Authors:  Xiang-Yu Zhang; Ting-Ting Ma; Lei Liu; Ning-Bei Yin; Zhen-Min Zhao
Journal:  Surg Radiol Anat       Date:  2016-06-11       Impact factor: 1.246

3.  A Rare Complication of Radiofrequency Tonsil Ablation: Horner Syndrome.

Authors:  Cuneyt Kucur; Isa Ozbay; Fatih Oghan; Nadir Yildirim; Zuhal Zeybek Sivas; Sibel Canbaz Kabay
Journal:  Case Rep Otolaryngol       Date:  2015-05-07

4.  Long-Term Follow-Up in Children with Anisocoria: Cocaine Test Results and Patient Outcome.

Authors:  Fabienne C Fierz; Christina Gerth-Kahlert
Journal:  J Ophthalmol       Date:  2017-12-04       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.